Timber Pharmaceuticals Inc
WKN: A3DWN5 / ISIN: US8870802084BiopharmX vs Neothetics vs Galena
| eröffnet am: | 11.04.17 13:05 von: | Temesta |
| neuester Beitrag: | 24.04.21 23:13 von: | Lauranodya |
| Anzahl Beiträge: | 57 | |
| Leser gesamt: | 33677 | |
| davon Heute: | 12 | |
bewertet mit 0 Sternen |
||
|
Seite:
1
|
||
11.04.17 13:05
#1
Temesta
BiopharmX vs Neothetics vs Galena
One of the most +++ biotech hot stocks +++ in 2017.
Who will make the run until 2040?
BiopharmX?
In Love, Temesta and friends
Who will make the run until 2040?
BiopharmX?
In Love, Temesta and friends
11.04.17 13:18
#2
Temesta
To gets a change is hopeful for live
BioPharmX is going to need to put the drug through (what will likely have to be) two phase III studies before it gets a chance at a commercialization green light, and that’s both costly and fraught with potential setbacks.
11.04.17 22:20
#4
Temesta
First round hits Neothetics + 17,73%
BiopharmX and Galena on 2nd place +/-
20.04.17 16:29
#10
Temesta
BiopharmX - see more news in the first hald of may
Based on the timing of the study completion, the company now plans to announce topline data from the trial in the first half of May (!)
28.04.17 20:59
#13
Temesta
BiopharmX Top Performer with News
Nice turn this week and top performance this month,
open your eyes,
Temesta and friends
open your eyes,
Temesta and friends
17.05.17 07:03
#15
stoffel_
Q1 Bericht
Q1-Bericht von Galena:
investors.galenabiopharma.com/investors/press-releases/press-release-details/2017/Galena-Biopharma-Reports-First-Quarter-2017-Financial-Results/default.aspx
Ich sehe ihn als Positiv
investors.galenabiopharma.com/investors/press-releases/press-release-details/2017/Galena-Biopharma-Reports-First-Quarter-2017-Financial-Results/default.aspx
Ich sehe ihn als Positiv
Seite:
1